Who
Adams Catherine Owen
Director
Company insider
Files Form 4 as: Director, Agios Pharmaceuticals; Chief Executive Officer, ACADIA Pharmaceuticals; Director, OptiNose.
In numbers
- Trades disclosed
- 43
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $500K
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 29 Jul 2020
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,927 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,927 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,950 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,950 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 25 Mar 2026filed 26 Mar 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $250K11,641 at $21.47 | filing |
| 25 Mar 2026filed 26 Mar 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $250K11,641 at $21.47 | filing |
| 24 Mar 2026filed 26 Mar 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —23,509 at $0.00 | filing |
| 24 Mar 2026filed 26 Mar 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,509 at $0.00 | filing |
| 24 Mar 2026filed 26 Mar 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,509 at $0.00 | filing |
| 24 Mar 2026filed 26 Mar 2026 | ACAD ACADIA PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —23,509 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —263,005 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | ACAD ACADIA Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —76,509 at $0.00 | filing |
News
Head-To-Head Comparison: ACADIA Pharmaceuticals (NASDAQ:ACAD) versus C4 Therapeutics (NASDAQ:CCCC)ACAD · tickerreport.com · 19 Oct 2026Critical Review: ACADIA Pharmaceuticals (NASDAQ:ACAD) and C4 Therapeutics (NASDAQ:CCCC)ACAD · dailypolitical.com · 15 Oct 2026ACADIA Pharmaceuticals (NASDAQ:ACAD) Cut to "Neutral" at UBS GroupACAD · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Adams Catherine Owen; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.